ProfileGDS5822 / ILMN_2805375
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 93% 96% 94% 94% 97% 94% 97% 95% 93% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1812.293
GSM1276600PDAC Late Ablation Control 21562.996
GSM1276601PDAC Late Ablation Control 31156.594
GSM1276602PDAC Late Ablation 1957.994
GSM1276603PDAC Late Ablation 21803.797
GSM1276604PDAC Late Ablation 31209.194
GSM1303940PDAC Late Ablation_anti-CTLA4 11832.397
GSM1303941PDAC Late Ablation_anti-CTLA4 21338.395
GSM1303942PDAC Late Ablation_anti-CTLA4 3971.193